Safety interm of risk factors of nausea or anorexia in patients with idiopathic pulmonary fibrosis treated with nintedanib
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Nintedanib (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions
Most Recent Events
- 06 Jul 2018 New trial record
- 23 May 2018 Results presented at the 114th International Conference of the American Thoracic Society